Cargando…

Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort

This retrospective analysis investigated plasma oxalate (POx) as a potential predictor of end-stage kidney disease (ESKD) among primary hyperoxaluria (PH) patients. PH patients with type 1, 2, and 3, age 2 or older, were identified in the Rare Kidney Stone Consortium (RKSC) PH Registry. Since POx in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Ronak Jagdeep, Vaughan, Lisa E., Enders, Felicity T., Milliner, Dawn S., Lieske, John C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279271/ https://www.ncbi.nlm.nih.gov/pubmed/32443777 http://dx.doi.org/10.3390/ijms21103608

Ejemplares similares

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria
por: Wang, Xiangling, et al.
Publicado: (2020)

Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones
por: Jayachandran, Muthuvel, et al.
Publicado: (2020)

Correction to: Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones
por: Jayachandran, Muthuvel, et al.
Publicado: (2021)

Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria
por: Tang, Xiaojing, et al.
Publicado: (2014)

Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies
por: Milliner, Dawn S., et al.
Publicado: (2021)

Successful Treatment of Primary Hyperoxaluria Type 2 with a Combined Liver and Kidney Transplant
por: Genena, Kareem M., et al.
Publicado: (2023)

Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis
por: Sas, David J., et al.
Publicado: (2021)

Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1
por: Metry, Elisabeth L, et al.
Publicado: (2023)

Clinical and molecular characterization of primary hyperoxaluria in Egypt
por: Soliman, Neveen A., et al.
Publicado: (2022)

Bilateral nephrocalcinosis in primary hyperoxaluria type 1
por: Mansoor, C. A., et al.
Publicado: (2016)

Application of multivariate joint modeling of longitudinal biomarkers and time-to-event data to a rare kidney stone cohort
por: Vaughan, Lisa E., et al.
Publicado: (2022)

In vivo oxalate degradation by liposome encapsulated oxalate oxidase in rat model of hyperoxaluria
por: Dahiya, Tulika, et al.
Publicado: (2013)

A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria
por: Milliner, Dawn, et al.
Publicado: (2017)

Plasma oxalate: comparison of methodologies
por: Stokes, Felicity, et al.
Publicado: (2020)

Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry
por: Metry, Elisabeth L., et al.
Publicado: (2021)

Primary hyperoxaluria type 1: novel therapies at a glance
por: Bacchetta, Justine, et al.
Publicado: (2022)

Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
por: Metry, Elisabeth L., et al.
Publicado: (2023)

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
por: Lai, Chengjung, et al.
Publicado: (2018)

Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type I
por: Recker, Pia, et al.
Publicado: (2022)

New Insights Regarding Organ Transplantation in Primary Hyperoxaluria Type 1
por: Sas, David J., et al.
Publicado: (2021)

Primary Hyperoxaluria
por: Harambat, Jérôme, et al.
Publicado: (2011)

Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures
por: Suryavanshi, Mangesh V., et al.
Publicado: (2016)

Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney
por: Duan, Xiaolu, et al.
Publicado: (2018)

Kidney Stones in Primary Hyperoxaluria: New Lessons Learnt
por: Jacob, Dorrit E., et al.
Publicado: (2013)

Hydroxycitric Acid Tripotassium Inhibits Calcium Oxalate Crystal Formation in the Drosophila Melanogaster Model of Hyperoxaluria
por: Han, Shanfu, et al.
Publicado: (2019)

An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria
por: Lubkowicz, David, et al.
Publicado: (2022)

Kidney Injury Molecule-1 Is Up-Regulated in Renal Epithelial Cells in Response to Oxalate In Vitro and in Renal Tissues in Response to Hyperoxaluria In Vivo
por: Khandrika, Lakshmipathi, et al.
Publicado: (2012)

Cerium oxide-based nanozyme suppresses kidney calcium oxalate crystal depositions via reversing hyperoxaluria-induced oxidative stress damage
por: Deng, Jiwang, et al.
Publicado: (2022)

Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1
por: Dutta, Chaitali, et al.
Publicado: (2016)

Primary hyperoxaluria and systemic oxalosis
por: Sriram, K., et al.
Publicado: (2007)

Evaluation of a high‐performance liquid chromatography method for urinary oxalate determination and investigation regarding the pediatric reference interval of spot urinary oxalate to creatinine ratio for screening of primary hyperoxaluria
por: Shen, Ying, et al.
Publicado: (2021)

Dominant negative mutation in oxalate transporter SLC26A6 associated with enteric hyperoxaluria and nephrolithiasis
por: Cornière, Nicolas, et al.
Publicado: (2022)

Retraction: Kidney Injury Molecule-1 Is Up-Regulated in Renal Epithelial Cells in Response to Oxalate In Vitro and in Renal Tissues in Response to Hyperoxaluria In Vivo
Publicado: (2020)

Genetic assessment in primary hyperoxaluria: why it matters
por: Mandrile, Giorgia, et al.
Publicado: (2022)

Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia
por: Pfau, Anja, et al.
Publicado: (2021)

Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass
por: Agrawal, Varun, et al.
Publicado: (2016)

Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: Inflammatory changes are mainly associated with crystal deposition
por: Joshi, Sunil, et al.
Publicado: (2017)

Pancytopenia as a Complication of Primary Hyperoxaluria
por: Khosravi, M., et al.
Publicado: (2019)

The Struggling Odyssey of Infantile Primary Hyperoxaluria
por: Guillaume, Adrien, et al.
Publicado: (2021)

Treatment of primary hyperoxaluria type 1
por: Gupta, Asheeta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dvcffknhqqbmekhlvo7g327kcg